NorthRock Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
3,176
-98
| -3% | -$43.6K | 0.04% | 179 |
|
|
2025
Q1 | $1.59M | Buy |
3,274
+349
| +12% | +$169K | 0.05% | 142 |
|
|
2024
Q4 | $1.18M | Sell |
2,925
-377
| -11% | -$152K | 0.04% | 181 |
|
|
2024
Q3 | $1.54M | Buy |
3,302
+67
| +2% | +$31.2K | 0.05% | 151 |
|
|
2024
Q2 | $1.52M | Buy |
3,235
+132
| +4% | +$61.9K | 0.06% | 144 |
|
|
2024
Q1 | $1.3M | Buy |
3,103
+281
| +10% | +$117K | 0.05% | 162 |
|
|
2023
Q4 | $1.15M | Buy |
2,822
+1,333
| +90% | +$542K | 0.05% | 168 |
|
|
2023
Q3 | $518K | Buy |
1,489
+514
| +53% | +$179K | 0.05% | 152 |
|
|
2023
Q2 | $343K | Buy |
975
+101
| +12% | +$35.5K | 0.04% | 193 |
|
|
2023
Q1 | $275K | Sell |
874
-255
| -23% | -$80.3K | 0.03% | 242 |
|
|
2022
Q4 | $326K | Buy |
1,129
+155
| +16% | +$44.8K | 0.04% | 233 |
|
|
2022
Q3 | $282K | Buy |
974
+47
| +5% | +$13.6K | 0.03% | 214 |
|
|
2022
Q2 | $261K | Buy |
+927
| New | +$261K | 0.03% | 248 |
|